InsidersTradesSigma
Waystar Holding Corp. Stock: price and insider trades · United States · SEC (Form 4)
Track the Waystar Holding Corp. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Waystar Holding Corp. has published 53 reports. Market capitalisation: €4.5bn. The latest transaction was reported on 9 June 2026 (Retenue fiscale). Among the most active insiders: BAIN CAPITAL INVESTORS LLC. The full history is openly available.
53
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€2bn
12 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Waystar Holding Corp. Strong Buy (bullish), based on 23 analysts. Average price target: US$33.52.
33Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 12,290 of 25,899 companies
53.4
score / 100
Value52
Quality55
FCF yld6.5%
Earn yld2.6%
EV/EBITDA15.0x
ROE3.6%
Gross mgn68%
Net mgn10%
Debt/EBITDA3.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 9 June 2026
Declarations53 total
12,212 sharesCommon StockSEC:0001998332-26-000004:0
4,295,139 shares@ US$39.2130.7% of flowCommon Stock, par value $0.01 per shareSEC:0001193125-25-205034:0
516,371 sharesCommon Stock, par value $0.01 per shareSEC:0001193125-25-205034:1
3,400 shares@ US$18.1950.0% of flowCommon StockSEC:0001998251-25-000004
3,400 shares@ US$18.190.0016% mcap50.0% of flowCommon StockSEC:0001998251-25-000004:0
85,000 shares@ US$37.092248.6% of flowCommon StockSEC:0001998332-25-000001:0
46,667 shares@ US$4.140.0048% mcap50.0% of flowCommon StockSEC:0001104659-25-068318:0
46,667 shares@ US$4.1450.0% of flowCommon StockSEC:0001104659-25-068318
9,702 shares@ US$4.14100.0% of flowCommon StockSEC:0001104659-25-052088:0
4,111,357 shares@ US$37.393732.4% of flowCommon StockSEC:0001104659-25-051037:0
3,012,253 shares@ US$37.3932.6% of flowCommon Stock, par value $0.01 per shareSEC:0000950170-25-075495:0
5,376,390 shares@ US$37.393732.4% of flowCommon StockSEC:0000950170-25-075228:0
3,012,253 shares@ US$37.3921.5% of flowCommon Stock, par value $0.01 per shareSEC:0000950170-25-075513:0
235,397 sharesCommon Stock, par value $0.01 per shareSEC:0000950170-25-075513:1
451,837 shares@ US$37.393.2% of flowCommon Stock, par value $0.01 per shareSEC:0000950170-25-075513:2
3,300 shares@ US$39.159840.5% of flowCommon StockSEC:0001104659-25-049882:0
46,667 shares@ US$4.1420.2% of flowCommon StockSEC:0001104659-25-048683:0
8,623 shares@ US$4.1432.9% of flowCommon StockSEC:0001104659-25-047354:0
264,131 shares0Common StockSEC:0001104659-25-047057:0
8,623 shares@ US$4.1432.8% of flowCommon StockSEC:0001104659-25-034705:0
46,667 shares@ US$4.1420.1% of flowCommon StockSEC:0001104659-25-034704:0
158,478 shares0Common StockSEC:0001104659-25-031491:0
211,304 shares0Common StockSEC:0001104659-25-031488:0
52,826 shares0Common StockSEC:0001104659-25-031496:0
264,131 shares0Common StockSEC:0001104659-25-031494:0
25 of 53 declarations
About Waystar Holding Corp.
Waystar Holding Corp. (ticker: WAY) is a U.S.-based healthcare software company listed on the Nasdaq market in the United States. For French-speaking investors, it is best understood as a B2B infrastructure provider sitting at the center of healthcare payment workflows and revenue cycle management for hospitals, physician groups, and other care providers. The company was originally incorporated in Delaware in August 2019, adopted the Waystar Holding Corp. name in August 2023, and completed its initial public offering in June 2024. Its principal offices are co-located in Lehi, Utah, and Louisville, Kentucky, underscoring a dual operational footprint in two major U.S. health-tech hubs. Waystar’s core business is a cloud-native software platform designed to simplify healthcare payments, reduce manual work, and improve providers’ financial performance. Its product suite spans patient access, claims management, payment processing, collections, denial prevention, and more recently AI-driven capabilities, including agentic and generative AI use cases. The company describes its enterprise-grade platform as processing more than 7.5 billion healthcare payment transactions annually, with over $2.4 trillion in annual gross claims, reaching approximately 60% of U.S. patients and one in three U.S. hospital discharges. These figures, highlighted by the company, illustrate the scale and embeddedness of its network, although investors should note they are company-reported metrics. From a competitive standpoint, Waystar is positioned as a leading revenue cycle management platform in a fragmented but mission-critical category. Its differentiation is based on software depth, workflow integration, automation, and an expanding AI layer. The company has also built meaningful brand credibility through repeated Best in KLAS recognition and several innovation awards tied to AI capabilities. Another milestone was its addition to the S&P SmallCap 600 index in September 2025, which typically increases visibility among institutional investors and index-tracking funds. Recent strategic developments have been particularly important. In July 2025, Waystar announced a definitive agreement to acquire Iodine Software for an enterprise value of $1.25 billion, a move aimed at strengthening its AI-powered transformation of healthcare payments. In 2026, the company continued to emphasize AI-led product expansion, including an expanded collaboration with Google Cloud in March and the launch in April of a solution targeting so-called “silent denials,” a large and often under-recognized source of provider revenue leakage. Overall, Waystar looks like a growth-oriented healthcare technology franchise with exposure to the U.S. market’s ongoing shift toward automated, data-driven payment infrastructure.
